EN 13726 Wound Dressing Test Methods and Sample Preparation

Three things to settle before anything else

For medical dressings going into the EU, the backbone method standard on the physical performance side is EN 13726, the test methods for primary wound dressings. It covers a family of methods - absorbency, moisture vapour transmission, waterproofness, conformability and others - but it says nothing about biological safety, and nothing about packaging integrity or shelf life. Those three are separate workstreams.

Second, an EN 13726 report cannot stand in for the YY/T 0471 report used in Chinese registration, and the reverse is equally true. The two follow similar test logic, but specimen preparation, test liquids and the way results are expressed are not fully equivalent. What a reviewer checks is whether the standard number lines up with the scope you are claiming.

Third, for most items this standard tells you how to measure, not what counts as a pass. Limits are normally declared by the manufacturer in the technical documentation; the laboratory issues measured values, and whether they pass depends on what you declared.

Once those three points are clear, the way you organise testing follows naturally: fix the product construction and the performance claims first, then fix the test list, then schedule. What follows is laid out in the order a laboratory actually works through an order - how items are selected, how samples should be prepared, and where jobs come back for rework.

Which test modules EN 13726 covers

Grouped by purpose, the methods in this standard fall into a few families. Understanding how they relate to each other matters more than memorising the names.

Absorbency. The core item is free swell absorptive capacity: how much simulated exudate a dressing takes up when it is neither compressed nor constrained. The test liquid is not pure water, and not ordinary saline either. It is the solution specified in the standard, containing sodium and calcium ions, which people in the trade usually just call "solution A". The point of the formulation is to reproduce the ionic strength of human exudate. Calcium in particular has a direct effect on the gelling behaviour of ion-exchange materials such as alginates and hydrofibres, so using the wrong liquid shifts results systematically. For the preparation method and concentrations, refer to the current valid version of the standard text.

Moisture vapour transmission. MVTR applies to semi-permeable film backings and to constructions that include a film. There are two test orientations. Upright, where the liquid does not touch the dressing, characterises the breathability of the backing itself. Inverted, where the liquid sits directly against the contact face, is much closer to how a dressing behaves on an exuding wound. The same dressing frequently gives results of a different order of magnitude between the two orientations, so the report must state which one was used. Otherwise whoever assembles the technical file downstream has no way to explain the number.

Fluid handling capacity (FHC). This combines what is absorbed with what evaporates away, giving a composite figure for how much exudate the dressing handles over one wear period. For foam dressings and film-laminated composites, this is closer to a wear-time or change-frequency claim than absorbency alone.

Waterproofness. This looks at the ability of the backing to keep external liquid out - the supporting data behind claims such as "can be worn in the shower". Note that it and MVTR run in opposite directions: one asks whether liquid water can get in, the other whether water vapour can get out. A good semi-permeable structure has to satisfy both, and there is inherent tension between them.

Dispersion characteristics. Mainly relevant to hydrocolloids, this looks at whether the dressing breaks up or disperses after taking up fluid, and whether residue is easy to remove at dressing change. Anyone who has collected clinical feedback will recognise this as the item behind complaints about gel residue left on the wound at removal.

Liquid affinity of gels. Amorphous hydrogels are a special case: they may donate moisture to the wound or draw moisture from it, and the direction depends on formulation and wound state. Conventional absorbency methods produce nothing meaningful on these products. The standard instead uses a simulated wound matrix to determine the direction and magnitude of donation or absorption. The most common ordering error on gel products is ticking the free swell absorptive capacity box.

Conformability. This looks at how well a dressing follows body contours, and matters for products used over joints or the sacral area.

The standard also addresses wet bacterial barrier properties. For how the modules are arranged, the test conditions and the reporting requirements, refer to the current valid version of EN 13726 itself. Do not place an order using clause numbers taken from old material.

Writing the test request: item names are more reliable than clause numbers

The way the modules are arranged in the standard text changes between versions, and the training material on your shelf, or the old list a supplier forwarded, may not match the current valid version. The safer way to write a test request is therefore standard number plus the name of the test item - "free swell absorptive capacity", "moisture vapour transmission rate (inverted)" - rather than throwing a string of clause numbers at the laboratory and expecting it to guess what you want. A request that gets accepted on the first pass usually makes four things explicit.

One, the standard and the version basis. State EN 13726 and note that it is to be run to the current valid version. If your EU customer or notified body has specified a different version basis, note that separately on the request so the laboratory can check it against the standard text when the order is taken, instead of both sides working from memory.

Two, the item list and the test orientation. Where an item has more than one orientation, such as moisture vapour transmission, say which one. If you need both, list both, and both will be reported separately. For structurally unusual products such as gels or island composites, also state whether the test object is the whole dressing or one specific layer.

Three, the sample state. Whether the product is already sterilised, by what method, whether the release liner is present, and whether it is in final packaging form. These determine directly whether the data can go into the technical file, and whether the laboratory needs to arrange additional pre-conditioning.

Four, how results are to be expressed, and your declared limits. For most items the laboratory issues measured values, and you have to state and justify your own declared limits in the technical file. If you want the report to carry a pass or fail statement, you must supply the declared specification when the order is placed. Without it the report can only give data, and adding a verdict afterwards means going through a report revision.

There is one more question that comes up constantly: are the old reports on file still usable? The basis for judging is whether the test method itself has changed in substance, and whether the items you cite are still within the scope of the current valid version - not whether the clause numbering has been rewritten. Go through the list with the laboratory before shipping samples rather than reworking once the report is out.

Choosing items by dressing type

This is one of the most frequent questions at order intake. The table below gives conventional item combinations by product construction, as a starting point only. The real combination depends on your performance claims: if you say it in the instructions for use, you have to test it.

A few notes on the table. For antimicrobial dressings containing silver or iodine, EN 13726 addresses physical performance only; antimicrobial efficacy and silver ion release sit on a separate track outside this standard and need their own validation design. For island composites - adhesive border with an absorbent core in the middle - agree in advance how the sampling area is defined for absorbency and MVTR: whole dressing or absorbent core only. The two conventions give different numbers, and the technical file has to be consistent throughout.

EN 13726 and YY/T 0471: can one set of samples produce two reports?

Whether samples can be shared and whether data can be shared are two different questions.

The practical recommendation is to prepare one sufficiently large batch of samples, schedule the two routes as separate test runs, and issue separate reports. That is faster than running one route, getting pushed back by the customer, and then adding the other. For the actual requirements, test conditions and assessment rules, both standards are to be applied in their current valid versions.

What to prepare before shipping samples

This section is pure field experience, and writing it down removes most of the back-and-forth.

Sample state. Send sterilised finished product, not semi-finished or unsterilised parts. Sterilisation, irradiation in particular, changes the properties of some polymer backings and hydrocolloid matrices, and data generated on unsterilised samples will not hold up in the technical file. If the product has a release liner, keep the original liner in place and do not peel it off in advance.

Do not cut specimens yourself. Each test item has its own rules for how specimens are taken. Samples that customers have trimmed themselves frequently arrive at the wrong size or with the edge seal destroyed, and have to be scrapped and reshipped. Sending whole finished dressings is simpler for everyone.

Quantity. Every item needs multiple replicate specimens, plus margin for retesting and retained samples, so real consumption is higher than most people estimate. Prepare to the replicate requirements in the standard and then add a buffer; confirm the exact number with the laboratory when the order is placed.

Size coverage. Whether one formulation can cover several sizes depends on what actually differs. Different thickness, different number of layers or a different backing material normally means testing separately. Where only the outline dimensions differ and the construction is identical, a coverage rationale is possible, but the reasoning has to be written into the technical file.

Extra information for products with active ingredients. For silver- or iodine-containing antimicrobial dressings, in addition to the usual documentation, state how the active is loaded - coating, blending, or an ion-exchange carrier - because the loading route affects how the dressing changes shape once it takes up fluid, and determines whether release behaviour studies are needed alongside the physical tests. Supply this at order intake and the laboratory can get the protocol right the first time.

Shipping and storage. Hydrogels, hydrocolloids and other water-containing or plasticised systems can change shape if they are compressed or heated in transit. Ship in the original sales packaging, avoid heavy stacking, and avoid long periods at elevated temperature. If samples arrive visibly deformed or leaking, the laboratory will normally check with you before deciding whether to start, which is better than finishing the tests and then discovering the data is anomalous.

Documents with the samples. An exploded or layer diagram, the material grades of each layer, the sterilisation method, and the claim wording in the instructions for use relating to absorbency and change frequency. That last item is often overlooked, but it drives the test list directly: claim an extended wear time and you need fluid handling capacity data to back it. For the full sample checklist and packing and shipping requirements, see testing requirements.

The frequent causes of rework

One, using saline or pure water instead of the specified test liquid. Some manufacturers take this shortcut for in-house checks, then query the laboratory when their own numbers do not match the third-party report. With a different ionic composition, the absorption behaviour of gelling materials is visibly different.

Two, choosing the wrong MVTR orientation. Upright data looking better than inverted data is routine, but if the product is positioned for moderate to heavy exudate and you only supply upright data, you will be asked about it at review.

Three, submitting gel products for absorbency testing. As above, the direction of measurement is wrong and no valid data comes out.

Four, starting testing without the specified conditioning. Dressings are mostly hygroscopic materials and ambient conditions have a direct effect on gravimetric tests. The standard sets requirements for conditioning before test; the specific conditions are per the current valid version of the standard text, and this step cannot be skipped.

Five, treating EN 13726 as the whole job. It is one leg only. Biological evaluation, packaging and shelf life still follow.

Six, changing formulation or supplier after the report is issued. A new backing film supplier or a different hydrocolloid grade can move both MVTR and absorbency. Do the change assessment properly rather than assuming the old report carries over.

An engineering aside: why absorbency and MVTR are hard to have at once

What follows is a qualitative analysis from materials and mass transport, not a statistical conclusion.

A dressing deals with exudate by two routes: storing it inside the substrate (absorption), and venting it as water vapour through the backing (transmission). The storage route depends on porosity and the density of hydrophilic groups - more pores and stronger hydrophilicity mean more fluid held, but substrate density and wet strength drop, and the dressing is more likely to tear or leave residue on removal. The venting route depends on the free volume and thickness of the backing - a thinner film with a polar group distribution favourable to water diffusion transmits more vapour, but the same structure has less resistance to liquid water and less mechanical strength, so waterproofness and abrasion resistance fall with it.

In formulation terms, chasing absorbency usually costs wet integrity, and chasing transmission usually costs waterproofness and strength. That is also why fluid handling capacity, which sums the two routes, is the more interesting figure: it lets you allocate between the routes rather than pushing hard on a single dimension. When positioning a product, work out the exudate level of the target wound first and then decide the split between the two routes. That is far cheaper than reworking the formulation once the report arrives.

Beyond EN 13726: what else the technical file needs

For a product in direct contact with a wound, the performance report is one piece only. A complete verification package normally has three further parts.

Biological evaluation: define the contact first, then the endpoints. Many manufacturers open with "which tests do we need", which already skips a step. Biological evaluation does not start from a test list; it starts from two facts: how the product contacts the body, and how long a single application lasts. Dressings normally fall into the surface contact category, and in most cases the contact is with breached skin or a wound, which carries stricter evaluation requirements than products contacting intact skin only. Contact duration is graded as limited, prolonged or long-term, with the boundaries per the current valid version of the standard text. Once those two dimensions are fixed, you work through the evaluation route and arrive at the endpoint list that belongs to your product, rather than one copied from a competitor's report.

The usual sequence is to characterise materials, gather existing data and justify its applicability, and only then decide which endpoints must be tested. Endpoints such as cytotoxicity are essentially unavoidable; whether sensitisation, irritation and others are needed, and how they are addressed, follows from the evaluation route. These are run under the relevant parts of the ISO 10993 series, with GB/T 16886 as the corresponding Chinese series. Which part applies and which edition is used should be confirmed against the current valid version of the standard text and your evaluation route, rather than copied from old material. One more reminder: biological evaluation applies to the finished product, so any change of formulation or sterilisation process means reassessing whether existing data still carries over. That is an easy thing to miss in change management. For the related items see biocompatibility testing.

Packaging and the sterile barrier. The packaging system for a sterile dressing is validated to ISO 11607, with the requirements for materials and preformed sterile barrier systems in ISO 11607-1. Seal strength, integrity, and performance retention after simulated distribution are all points reviewers pursue; see packaging validation.

Shelf life. Accelerated and real-time ageing run in parallel, and key performance is retested after ageing. For dressings, absorbency, MVTR and adhesion are typical time-sensitive items. See shelf-life validation for how this is arranged.

On sequencing: biological evaluation and the EN 13726 performance tests can run in parallel. Packaging and shelf life depend on the finished product and final packaging being frozen, so they come later. If the formulation is still moving, run small-scale scoping first and start formal validation once the design is fixed; that avoids a great deal of retesting.

What we can do

SUNGO Lab has long handled performance and safety verification for medical dressings and single-use medical consumables. The laboratory is accredited by CNAS, CMA and IAS (USA), with facilities in Shanghai and Hefei. To be clear, an accreditation mark only demonstrates that the laboratory has the technical competence within its accredited scope; it is not a commitment as to market access. Whether a product is approved for market depends on the completeness of the technical documentation and the assessment of the competent authority. For dressing products we can help map out the test lists for both the EN 13726 and YY/T 0471 routes, settle the sample and size coverage plan, and arrange the accompanying biological evaluation, packaging validation and shelf-life studies, issuing reports usable in EU technical documentation and in Chinese registration filings. Turnaround, sample quantity and cost all depend on the item combination, so it is worth sending us the product construction drawing and the claim wording first and fixing the list in one pass. You can reach us on +86 132 4819 8029, or request a quote.